| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Kelly Timothy Edwin serves as a Chief Financial Officer at PRAX. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $5.2M at current prices.
Historically, Kelly Timothy Edwin's trades have earned a below-average insider score of 38/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -9.3%.
The biggest single holding is PRAX (~$5.2M) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 21,905 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 8,000 | $0.87 | $6,997.60 | +20.8% | +40.7% | +339.5% | |
| Jun 9, 2022 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 10,000 | $1.77 | $17,650.00 | +32.8% | +81.1% | -43.5% | |
| Aug 31, 2021 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 3,905 | $19.48 | $76,069.40 | New | -14.0% | -84.3% |